Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4572-4585

  Santiago, Felix W ^a   Covaleda, Lina M ^a   Sanchez Aparicio, Maria T ^b   Silvas, Jesus A ^a   Diaz Vizarreta, Ana C ^a   Patel, Jenish R ^b   Popov, Vsevolod ^a,c   Yu, Xue Jie ^a   García Sastre, Adolfo ^b   Aguilar, Patricia V ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PROTEIN TBK1; PROTEIN TRIM25; RAB PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; ATG7 GENE; AUTOPHAGY; CELL STRUCTURE; CONFOCAL MICROSCOPY; CYTOKINE RESPONSE; CYTOPLASM; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RIG I GENE; RNA VIRUS; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INDUCED CYTOPLASMIC STRUCTURE;

BUNYAVIRIDAE INFECTIONS; CELL LINE; CYTOPLASMIC STRUCTURES; DEAD-BOX RNA HELICASES; ENDOSOMES; HUMANS; INTERFERON TYPE I; PHLEBOVIRUS; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84896930327     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03021-13     Document Type: Article

References (74)

1. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820. http://dx.doi.org/10.1016/j.cell.2010.01.022.
2. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
3. Meylan E, Tschopp J, Karin M. 2006. Intracellular pattern recognition receptors in the host response. Nature 442:39-44. http://dx.doi.org/10.1038/nature04946.
4. Yoneyama M, Fujita T. 2007. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev. 18: 545-551. http://dx.doi.org/10.1016/j.cytogfr.2007.06.023.
5. Baum A, García-Sastre A. 2010. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 38:1283-1299. http://dx.doi.org/10.1007/s00726-009-0374-0.
6. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol. Rev. 227:75-86. http://dx.doi.org/10.1111/j.1600-065X.2008.00737.x.
7. Yoneyama M, Fujita T. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29:178-181. http://dx.doi.org/10.1016/j.immuni.2008.07.009.
8. Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227:54-65. http://dx.doi.org/10.1111/j.1600-065X.2008.00727.x.
9. Yount JS, Gitlin L, Moran TM, López CB. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J. Immunol. 180:4910-4918.
10. Melchjorsen J, Jensen SB, Malmgaard L, Rasmussen SB, Weber F, Bowie AG, Matikainen S, Paludan SR. 2005. Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J. Virol. 79:12944-12951. http://dx.doi.org/10.1128/JVI.79.20.12944-12951.2005.
11. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010.
12. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E, Reis e Sousa C. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408. http://dx.doi.org/10.1016/j.cell.2010.01.020.
13. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997. http://dx.doi.org/10.1126/science.1132505.
14. Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001. http://dx.doi.org/10.1126/science.1132998.
15. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
16. Feng Q, Hato SV, Langereis MA, Zoll J, Virgen-Slane R, Peisley A, Hur S, Semler BL, van Rij RP, van Kuppeveld FJ. 2012. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2:1187-1196. http://dx.doi.org/10.1016/j.celrep.2012.10.005.
17. Kato H, Takahasi K, Fujita T. 2011. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 243:91-98. http://dx.doi.org/10.1111/j.1600-065X.2011.01052.x.
18. Habjan M, Andersson I, Klingström J, Schümann M, Martin A, Zimmermann P, Wagner V, Pichlmair A, Schneider U, Mühlberger E, Mirazimi A, Weber F. 2008. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3:e2032. http://dx.doi.org/10.1371/journal.pone.0002032.
19. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137. http://dx.doi.org/10.1038/ni1303.
20. Oshiumi H, Miyashita M, Matsumoto M, Seya T. 2013. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9:e1003533. http://dx.doi.org/10.1371/journal.ppat.1003533.
21. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. http://dx.doi.org/10.1038/nature05732.
22. Gack MU, Kirchhofer A, Shin YC, Inn KS, Liang C, Cui S, Myong S, Ha T, Hopfner KP, Jung JU. 2008. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. U. S. A. 105:16743-16748. http://dx.doi.org/10.1073/pnas.0804947105.
23. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, Chen ZJ. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315-330. http://dx.doi.org/10.1016/j.cell.2010.03.029.
24. García-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 312:879-882. http://dx.doi.org/10.1126/science.1125676.
25. Haller O, Kochs G, Weber F. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119-130. http://dx.doi.org/10.1016/j.virol.2005.09.024.
26. Bridgen A, Weber F, Fazakerley JK, Elliott RM. 2001. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:664-669. http://dx.doi.org/10.1073/pnas.98.2.664.
27. Blakqori G, Delhaye S, Habjan M, Blair CD, Sánchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, Weiss S, Michiels T, Staeheli P, Weber F. 2007. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J. Virol. 81:4991-4999. http://dx.doi.org/10.1128/JVI.01933-06.
28. Elliott RM, Weber F. 2009. Bunyaviruses and the type I interferon system. Viruses 1:1003-1021. http://dx.doi.org/10.3390/v1031003.
29. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. 2009. Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E75-E85. http://dx.doi.org/10.1111/j.1749-6632.2009.05054.x.
30. Le May N, Mansuroglu Z, Léger P, Josse T, Blot G, Billecocq A, Flick R, Jacob Y, Bonnefoy E, Bouloy M. 2008. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog. 4:e13. http://dx.doi.org/10.1371/journal.ppat.0040013.
31. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. 2004. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541-550. http://dx.doi.org/10.1016/S0092-8674(04)00132-1.
32. Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F. 2009. NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNAdependent protein kinase. J. Virol. 83:4365-4375. http://dx.doi.org/10.1128/JVI.02148-08.
33. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. 2009. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog. 5:e1000287. http://dx.doi.org/10.1371/journal.ppat.1000287.
34. Kalveram B, Lihoradova O, Ikegami T. 2011. NSs protein of Rift Valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J. Virol. 85:6234-6243. http://dx.doi.org/10.1128/JVI.02255-10.
35. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, Qu J, Li Q, Zhang YP, Hai R, Wu W, Wang Q, Zhan FX, Wang XJ, Kan B, Wang SW, Wan KL, Jing HQ, Lu JX, Yin WW, Zhou H, Guan XH, Liu JF, Bi ZQ, Liu GH, Ren J, Wang H, Zhao Z, Song JD, He JR, Wan T, Zhang JS, Fu XP, Sun LN, Dong XP, Feng ZJ, Yang WZ, Hong T, Zhang Y, Walker DH, Wang Y, Li DX. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364:1523-1532. http://dx.doi.org/10.1056/NEJMoa1010095.
36. Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ, Li J, Sun Q, Luo XL, Cheng YL, Qin XC, Tian JH, Chen XP, Yu B, Jin D, Guo WP, Li W, Wang W, Peng JS, Zhang GB, Zhang S, Chen XM, Wang Y, Li MH, Li Z, Lu S, Ye C, de Jong MD, Xu J. 2012. Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin. Infect. Dis. 54:527-533. http://dx.doi.org/10.1093/cid/cir804.
37. Zhang YZ, Zhou DJ, Xiong Y, Chen XP, He YW, Sun Q, Yu B, Li J, Dai YA, Tian JH, Qin XC, Jin D, Cui Z, Luo XL, Li W, Lu S, Wang W, Peng JS, Guo WP, Li MH, Li ZJ, Zhang S, Chen C, Wang Y, de Jong MD, Xu J. 2011. Hemorrhagic fever caused by a novel tick-borne bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi 32:209-220. (In Chinese.)
38. Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, Zhang F, Li C, Zhang Q, Zhu H, Chen T, Han Y, Zhang W, Zhang S, Wang Q, Sun L, Liu Q, Li J, Wang T, Wei Q, Wang S, Deng Y, Qin C, Li D. 2012. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc. Natl. Acad. Sci. U. S. A. 109:10053-10058. http://dx.doi.org/10.1073/pnas.1120246109.
39. Qu B, Qi X, Wu X, Liang M, Li C, Cardona CJ, Xu W, Tang F, Li Z, Wu B, Powell K, Wegner M, Li D, Xing Z. 2012. Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J. Virol. 86:8388-8401. http://dx.doi.org/10.1128/JVI.00612-12.
40. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, Ezaki J, Mizushima N, Ohsumi Y, Uchiyama Y, Kominami E, Tanaka K, Chiba T. 2005. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169:425-434. http://dx.doi.org/10.1083/jcb.200412022.
41. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728. http://dx.doi.org/10.1093/emboj/19.21.5720.
42. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, García-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449. http://dx.doi.org/10.1016/j.chom.2009.04.006.
43. Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martínez-Sobrido L, de la Torre JC, Kunz S. 2012. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKe. J. Virol. 86: 7728-7738. http://dx.doi.org/10.1128/JVI.00187-12.
44. Patel JR, Jain A, Chou YY, Baum A, Ha T, García-Sastre A. 2013. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep. 14:780-787. http://dx.doi.org/10.1038/embor.2013.102.
45. Aguilar PV, Weaver SC, Basler CF. 2007. Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J. Virol. 81: 3866-3876. http://dx.doi.org/10.1128/JVI.02075-06.
46. Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, García-Sastre A, Palese P. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. U. S. A. 97:12289-12294. http://dx.doi.org/10.1073/pnas.220398297.
47. Cao Z, Li C, Higginbotham JN, Franklin JL, Tabb DL, Graves-Deal R, Hill S, Cheek K, Jerome WG, Lapierre LA, Goldenring JR, Ham AJ, Coffey RJ. 2008. Use of fluorescence-activated vesicle sorting for isolation of Naked2-associated, basolaterally targeted exocytic vesicles for proteomics analysis. Mol. Cell. Proteomics 7:1651-1667. http://dx.doi.org/10.1074/mcp. M700155-MCP200.
48. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77:7945-7956. http://dx.doi.org/10.1128/JVI.77.14.7945-7956.2003.
49. Cárdenas WB, Loo YM, Gale M, Hartman AL, Kimberlin CR, Martínez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production in-duced by RIG-I signaling. J. Virol. 80:5168-5178. http://dx.doi.org/10.1128/JVI.02199-05.
50. Prins KC, Cárdenas WB, Basler CF. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 83:3069-3077. http://dx.doi.org/10.1128/JVI.01875-08.
51. Servant MJ, ten Oever B, LePage C, Conti L, Gessani S, Julkunen I, Lin R, Hiscott J. 2001. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276: 355-363. http://dx.doi.org/10.1074/jbc. M007790200.
52. Weaver BK, Kumar KP, Reich NC. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNAactivated transcription factor DRAF1. Mol. Cell. Biol. 18:1359-1368.
53. Kerppola TK. 2006. Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell Biol. 7:449-456. http://dx.doi.org/10.1038/nrm1929.
54. Miller S, Krijnse-Locker J. 2008. Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 6:363-374. http://dx.doi.org/10.1038/nrmicro1890.
55. Cash P. 1982. Inhibition of La Crosse virus replication by monensin, monovalent ionophore. J. Gen. Virol. 59:193-196. http://dx.doi.org/10.1099/0022-1317-59-1-193.
56. Nakitare GW, Elliott RM. 1993. Expression of the Bunyamwera virus M genome segment and intracellular localization of NSm. Virology 195:511-520. http://dx.doi.org/10.1006/viro.1993.1402.
57. Lappin DF, Nakitare GW, Palfreyman JW, Elliott RM. 1994. Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm. J. Gen. Virol. 75(Pt 12):3441-3451. http://dx.doi.org/10.1099/0022-1317-75-12-3441.
58. Zeigerer A, Gilleron J, Bogorad RL, Marsico G, Nonaka H, Seifert S, Epstein-Barash H, Kuchimanchi S, Peng CG, Ruda VM, Del Conte-Zerial P, Hengstler JG, Kalaidzidis Y, Koteliansky V, Zerial M. 2012. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 485:465-470. http://dx.doi.org/10.1038/nature11133.
59. Woodman PG. 2000. Biogenesis of the sorting endosome: the role of Rab5. Traffic 1:695-701. http://dx.doi.org/10.1034/j.1600-0854.2000.010902.x.
60. Stone M, Jia S, Heo WD, Meyer T, Konan KV. 2007. Participation of Rab5, an early endosome protein, in hepatitis C virus RNA replication machinery. J. Virol. 81:4551-4563. http://dx.doi.org/10.1128/JVI.01366-06.
61. Cheng CY, Shih WL, Huang WR, Chi PI, Wu MH, Liu HJ. 2012. Bovine ephemeral fever virus uses a clathrin-mediated and dynamin 2-dependent endocytosis pathway that requires Rab5 and Rab7 as well as microtubules. J. Virol. 86:13653-13661. http://dx.doi.org/10.1128/JVI.01073-12.
62. Huang WR, Wang YC, Chi PI, Wang L, Wang CY, Lin CH, Liu HJ. 2011. Cell entry of avian reovirus follows a caveolin-1-mediated and dynamin-2-dependent endocytic pathway that requires activation of p38 mitogen-activated protein kinase (MAPK) and Src signaling pathways as well as microtubules and small GTPase Rab5 protein. J. Biol. Chem. 286: 30780-30794. http://dx.doi.org/10.1074/jbc. M111.257154.
63. Garrison AR, Radoshitzky SR, Kota KP, Pegoraro G, Ruthel G, Kuhn JH, Altamura LA, Kwilas SA, Bavari S, Haucke V, Schmaljohn CS. 2013. Crimean-Congo hemorrhagic fever virus utilizes a clathrin-and early endosome-dependent entry pathway. Virology 444:45-54. http://dx.doi.org/10.1016/j.virol.2013.05.030.
64. Lozach PY, Mancini R, Bitto D, Meier R, Oestereich L, Overby AK, Pettersson RF, Helenius A. 2010. Entry of bunyaviruses into mammalian cells. Cell Host Microbe 7:488-499. http://dx.doi.org/10.1016/j.chom.2010.05.007.
65. Stenmark H, Olkkonen VM. 2001. The Rab GTPase family. Genome Biol. 2:REVIEWS3007. http://dx.doi.org/10.1186/gb-2001-2-5-reviews3007.
66. Weber M, Gawanbacht A, Habjan M, Rang A, Borner C, Schmidt AM, Veitinger S, Jacob R, Devignot S, Kochs G, García-Sastre A, Weber F. 2013. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 13:336-346. http://dx.doi.org/10.1016/j.chom.2013.01.012.
67. Huang NE, Lin CH, Lin YS, Yu WC. 2003. Modulation of YY1 activity by SAP30. Biochem. Biophys. Res. Commun. 306:267-275. http://dx.doi.org/10.1016/S0006-291X(03)00966-5.
68. Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T. 2013. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus. PLoS Negl. Trop. Dis. 7:e2181. http://dx.doi.org/10.1371/journal.pntd.0002181.
69. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, Shimizu S. 2009. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461:654-658. http://dx.doi.org/10.1038/nature08455.
70. Shimizu S, Arakawa S, Nishida Y. 2010. Autophagy takes an alternative pathway. Autophagy 6:290-291. http://dx.doi.org/10.4161/auto.6.2.11127.
71. de Haan CA, Molinari M, Reggiori F. 2010. Autophagy-independent LC3 function in vesicular traffic. Autophagy 6:994-996. http://dx.doi.org/10.4161/auto.6.7.13309.
72. Reggiori F, de Haan CA, Molinari M. 2011. Unconventional use of LC3 by coronaviruses through the alleged subversion of the ERAD tuning pathway. Viruses 3:1610-1623. http://dx.doi.org/10.3390/v3091610.
73. Blümer J, Rey J, Dehmelt L, Mazel T, Wu YW, Bastiaens P, Goody RS, Itzen A. 2013. RabGEFs are a major determinant for specific Rab membrane targeting. J. Cell Biol. 200:287-300. http://dx.doi.org/10.1083/jcb.201209113.
74. Fliss PM, Jowers TP, Brinkmann MM, Holstermann B, Mack C, Dickinson P, Hohenberg H, Ghazal P, Brune W. 2012. Viral mediated redirection ofNEMO/IKK γ to autophagosomes curtails the inflammatory cascade. PLoS Pathog. 8:e1002517. http://dx.doi.org/10.1371/journal.ppat.1002517.